ArticleHIV medicine2025
Factors mediating and associated with immunological response in women living with HIV in Sweden: A nationwide register-based study.
Article in HIV medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
introductionWomen remain underrepresented in studies on immunological response (IR) among virally suppressed people living with HIV. Despite receiving antiretroviral therapy (ART) some individuals do not attain an IR, increasing their risk of non-AIDS morbidity and mortality. This nationwide study investigated biomedical and social factors associated with IR among women with HIV in Sweden.
methodsWe conducted a register-based cohort study using the Swedish National HIV Registry (InfCareHIV). Virally suppressed women diagnosed with HIV between 2000 and 2020, ≥18 years old were included. Included women were observed for 2 years after ART initiation. The associations between IR and clinical and social determinants were investigated using logistic regression.
resultsThere were 841 women included in the final model, of whom 90% (n = 739, 95% CI: 0.88-0.92) had an IR after a 2-year follow-up. Mean age was 37 years at inclusion, and 52% (n = 439) were born in a sub-Saharan African country. A significant interaction between baseline HIV viral load and HIV acquisition mode was observed. Higher baseline HIV viral load (≥100 000 copies/mL) increased the odds of IR (adjOR 1.81, 95% CI: 0.96-3.41), except among women acquiring HIV via intravenous drug use (IDU), where this association was strongly attenuated (adjOR: 0.03; 95% CI: 0.01-0.35). Baseline CD4, ART experience and age showed no significant associations.
conclusionsThe relationship between higher baseline HIV viral load and improved IR differed by HIV acquisition mode, suggesting the importance of tailored interventions addressing social determinants and immune activation. This potential interaction needs to be validated in future studies, also including sex-specific variables.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.